Ballast Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Buy
20,259
+7,320
+57% +$591K 0.3% 58
2026
Q1
$1.12M Buy
12,939
+151
+1% +$14.5K 0.26% 67
2025
Q4
$1.23M Sell
12,788
-278
-2% -$27K 0.29% 60
2025
Q3
$1.24M Sell
13,066
-130
-1% -$11.9K 0.3% 60
2025
Q2
$1.15M Buy
13,196
+1,065
+9% +$90.3K 0.3% 60
2025
Q1
$1.09M Buy
12,131
+61
+0.5% +$5.46K 0.31% 60
2024
Q4
$964K Buy
12,070
+2,114
+21% +$183K 0.28% 63
2024
Q3
$896K Sell
9,956
-47
-0.5% -$3.95K 0.25% 62
2024
Q2
$787K Buy
10,003
+1,549
+18% +$127K 0.24% 65
2024
Q1
$737K Buy
8,454
+1,375
+19% +$117K 0.23% 65
2023
Q4
$583K Sell
7,079
-3,890
-35% -$296K 0.2% 68
2023
Q3
$860K Buy
10,969
+551
+5% +$46.1K 0.34% 52
2023
Q2
$918K Buy
10,418
+317
+3% +$27.3K 0.35% 51
2023
Q1
$814K Buy
10,101
+472
+5% +$38.5K 0.33% 56
2022
Q4
$748K Buy
9,629
+759
+9% +$61.5K 0.33% 57
2022
Q3
$716K Buy
8,870
+513
+6% +$46.1K 0.35% 50
2022
Q2
$750K Sell
8,357
-189
-2% -$19.1K 0.35% 58
2022
Q1
$948K Buy
8,546
+1,652
+24% +$175K 0.37% 52
2021
Q4
$713K Buy
6,894
+811
+13% +$93.9K 0.28% 59
2021
Q3
$762K Buy
6,083
+159
+3% +$20.6K 0.32% 48
2021
Q2
$735K Buy
5,924
+412
+7% +$51.7K 0.31% 51
2021
Q1
$651K Buy
5,512
+1,089
+25% +$128K 0.31% 49
2020
Q4
$518K Sell
4,423
-303
-6% -$33.4K 0.26% 53
2020
Q3
$491K Buy
4,726
+46
+1% +$4.62K 0.28% 58
2020
Q2
$429K Buy
4,680
+189
+4% +$18.1K 0.27% 65
2020
Q1
$404K Buy
4,491
+726
+19% +$77.2K 0.29% 60
2019
Q4
$427K Buy
3,765
+302
+9% +$33.1K 0.24% 64
2019
Q3
$376K Sell
3,463
-115
-3% -$12K 0.23% 68
2019
Q2
$348K Buy
3,578
+59
+2% +$5.39K 0.22% 72
2019
Q1
$320K Buy
3,519
+302
+9% +$27K 0.21% 76
2018
Q4
$293K Sell
3,217
-6
-0.2% -$561 0.23% 67
2018
Q3
$319K Hold
3,223
0.22% 70
2018
Q2
$276K Buy
3,223
+310
+11% +$25.9K 0.21% 72
2018
Q1
$235K Hold
2,913
0.19% 76
2017
Q4
$237K Buy
+2,913
New +$233K 0.2% 75

Other funds holding MDT

Ballast Inc's MDT Position: Q2 2026 in Review

Ballast Inc increased its Medtronic (MDT) stake by 57% in Q2 2026, buying an estimated $591K and bringing the position to 20,259 shares worth $1.58M. The position accounts for 0.3% of the portfolio, ranked #58.

Ballast Inc first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ballast Inc held 20,259 shares of Medtronic worth $1.58M as of Q2 2026.
  • Ballast Inc bought 7,320 Medtronic shares in Q2 2026, an estimated $591K.
  • Medtronic made up 0.3% of Ballast Inc's portfolio in Q2 2026, its #58 holding.
  • Ballast Inc first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ballast Inc's 13F filing for Q2 2026, filed 10 Jul 2026.